AAV Episomal Dilution: Understanding Vector Genome Loss in Gene Therapy

What Episomal Dilution Is

Episomal dilution refers to the process where an adeno-associated virus (AAV) vector genome, which remains episomal and does not integrate into the host cell's genome, gets diluted among daughter cells during cell division. This phenomenon is crucial in gene therapy because it directly influences the long-term expression of therapeutic genes.

In liver-targeted AAV-based gene therapies, each hepatocyte division results in a random distribution of vector copies between the two resulting cells. Over time, this leads to a decrease in the number of transduced cells and, consequently, in the overall level of transgene expression.

Why It Happens

Episomal dilution occurs due to the stochastic nature of cell division. Each time a hepatocyte divides, it randomly distributes its episomal AAV vector copies between the two daughter cells. This randomness means that some daughter cells may receive no copies at all, while others might inherit multiple copies.

The binomial distribution of vector copies among daughter cells leads to a gradual decrease in the fraction of transduced cells over time, which is why this process is often referred to as 'binomial dilution'.

Real-World Implications

Understanding episomal dilution is essential for optimizing gene therapy protocols. By predicting and mitigating the effects of vector genome loss, researchers can improve treatment efficacy and patient outcomes.

Clinical trials often need to account for episomal dilution when designing dosing regimens and assessing long-term therapeutic benefits.

Case Studies and Examples

For instance, in clinical settings, AAV-based gene therapies targeting liver diseases like hemophilia B or ornithine transcarbamylase deficiency have shown variable efficacy due to episomal dilution. By understanding these dynamics, researchers can develop strategies to enhance vector delivery and improve patient response.

In preclinical models, scientists use mathematical modeling and simulations similar to the one described here to predict the impact of different dosing regimens and cell division rates on transgene expression levels.

Frequently asked questions

Try it live

Everything above runs in your browser — open AAV Episomal Dilution: Vector Genome Loss in a Growing Liver (2D) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.